Nexstim Oyj (NXTMH.HE) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Finland · ISIN FI4000506811

Price
8.87 EUR
Market cap
64.17 m EUR
P/E (2025)
147.83
P/S (2025)
5.85
Dividend yield
0.00 %
Net margin
5.23 %
Return on equity (ROE)
13.71 %
Return on assets (ROA)
4.35 %

Nexstim Oyj financials

Fiscal year20242025
Revenue8.74 m EUR10.97 m EUR
Gross profit8.38 m EUR3.86 m EUR
Operating income-535,436.00 EUR630,200.00 EUR
EBIT-400,946.00 EUR630,200.00 EUR
Net income-892,288.00 EUR573,200.00 EUR
Diluted EPS – continuing operations-0.13 EUR0.06 EUR

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Nexstim Oyj

Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company offers non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS), including Navigated Brain Stimulation (NBS) system 6 for presurgical mapping of the speech and motor cortices of the brain, for the treatment of major depression and chronic unilateral neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb. The company markets and sells its diagnostics systems to universities and teaching hospitals. It has an exclusive collaboration with Sinaptica Therapeutics, Inc. for the development, manufacture, and delivery of precision neuromodulation system for the treatment of Alzheimer's disease and mild cognitive impairment; and a development and distribution collaboration with Brainlab AG for motor and speech mapping systems. The company was incorporated in 2000 and is headquartered in Helsinki, Finland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.